<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5C1114A7-CE62-4DEC-BB95-695D6E2666CF"><gtr:id>5C1114A7-CE62-4DEC-BB95-695D6E2666CF</gtr:id><gtr:name>University of Verona</gtr:name><gtr:address><gtr:line1>strada le Grazie 15</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AA92B0F3-5C79-4E66-8CF7-487AA58E4AF6"><gtr:id>AA92B0F3-5C79-4E66-8CF7-487AA58E4AF6</gtr:id><gtr:name>Quadram Institute Bioscience</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:department>Norwich Medical School</gtr:department><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5C1114A7-CE62-4DEC-BB95-695D6E2666CF"><gtr:id>5C1114A7-CE62-4DEC-BB95-695D6E2666CF</gtr:id><gtr:name>University of Verona</gtr:name><gtr:address><gtr:line1>strada le Grazie 15</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AA92B0F3-5C79-4E66-8CF7-487AA58E4AF6"><gtr:id>AA92B0F3-5C79-4E66-8CF7-487AA58E4AF6</gtr:id><gtr:name>Quadram Institute Bioscience</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1CAED802-33E5-42D4-9A30-D8C729835995"><gtr:id>1CAED802-33E5-42D4-9A30-D8C729835995</gtr:id><gtr:firstName>Stephanie</gtr:firstName><gtr:surname>Schuller</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ002062%2F1"><gtr:id>9566B41A-E11E-47CE-9BE9-1713EE06CC92</gtr:id><gtr:title>Shiga toxin translocation across human intestinal epithelium in a microaerobic infection model</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J002062/1</gtr:grantReference><gtr:abstractText>Shiga toxin-producing E. coli bacteria (STEC) are a leading cause of foodborne illness worldwide. In humans, STEC infection often causes severe bloody diarrhoea and abdominal cramps. In some persons, particularly children under five years of age and the elderly, the infection can also cause a complication called haemolytic uraemic syndrome (HUS), in which red blood cells are destroyed and small blot clots develop which can lead to kidney damage and failure. The HUS fatality rate is around 5%, and up to 40% of HUS patients suffer from long-term renal dysfunction. So far, there is no specific medication available, and treatment is merely supportive involving dialysis and blood transfusion.

After ingestion via contaminated food or water, STEC bacteria adhere to the intestinal lining and produce a toxin (Shiga toxin), which moves from the gut to the kidneys to cause HUS. It is not known how this happens as there are no appropriate experimental model systems available to study this process.
We have recently developed a human gut cell culture system which enables us to study STEC infections at reduced oxygen levels. Usually, such kind of infection experiments are performed in air (which contains 20% oxygen) to keep the host cells alive. However, the environment in the gut only contains around 1-5% oxygen which (amongst other factors) has been shown to provide a signal to the bacteria that they have reached their final destination. Results from our previous study have confirmed this for STEC bacteria and have shown that low oxygen levels increase the production of bacterial factors which promote colonisation of the gut wall. In addition, reduced oxygen levels also lead to the production of bacterial components which increase toxin movement across the gut wall.

In this application, we propose to continue these studies to determine (1) how the toxin crosses the gut barrier, (2) how the bacteria facilitate this process and which bacterial factors are switched on by low oxygen levels, and (3) whether STEC bacteria which produce high amounts of toxin and/or are good at moving toxin across the gut wall, cause more serious disease in humans.

The information obtained by the proposed study will help understand the early events that occur in the human gut after STEC infection and might contribute to the development of treatment strategies against HUS and STEC vaccine development.</gtr:abstractText><gtr:technicalSummary>Shiga toxin-producing E. coli (STEC) are foodborne pathogens that cause bloody diarrhoea and severe systemic complications such as haemolytic uraemic syndrome (HUS). HUS is the leading cause of acute renal failure in children and associated with production of bacterial Shiga toxins (Stx), which are highly cytotoxic to renal microvascular endothelium. After ingestion via contaminated food or water, STEC colonise the intestinal epithelium but do not invade. Therefore, Stx has to cross the intestinal epithelial barrier to get access into the bloodstream. The mode of Stx translocation across human intestinal epithelium, which lacks the Stx receptor (Gb3) and is resistant to Stx cytotoxicity, is unknown. Progress has been hampered by the absence of a suitable model for experimental study.

We have recently established an experimental system based on polarised monolayers of Gb3-negative human colon carcinoma cells in a vertical diffusion chamber (VDC) which allows to perform infections under microaerobic (MA) conditions. Most cell culture infection models use atmospheric oxygen levels to maintain cell viabilty, but this is unlike the intestinal milieu where oxygen is restricted. Using the VDC system, we have shown that microaerobiosis enhances STEC type III secretion and colonisation and also promotes Stx2 translocation during STEC infection. As this latter effect was only observed in the context of infection and not with purified Stx2 alone, these results lead to the hypothesis that MA conditions induce STEC factors which promote Stx2 translocation across human intestinal epithelium.

In this application, we propose to continue the MA VDC studies to (1) characterise the Stx transport pathway during MA infection, (2) to identify STEC factors which are induced during MA infection and test their involvement in Stx2 translocation, and (3) to examine whether Stx2 production and translocation during infection are linked to human virulence.</gtr:technicalSummary><gtr:potentialImpactText>This proposal falls within the MRC priority area of emerging pathogens and mainly addresses the &amp;quot;Improvement to health and life quality&amp;quot; remit of the MRC. STEC have only been linked to haemorrhagic colitis and HUS since 1983, and epidemiological studies show a considerable increase in HUS rates associated with more recent outbreaks (from 5 to more than 33% as observed in the current STEC outbreak in northern Germany) indicating the emergence of highly virulent strains. HUS usually requires hospitalisation for two weeks with dialysis and blood transfusion, and 40% of HUS patients suffer from chronic, irreversible renal dysfunction. Therefore, STEC infections are not only associated with considerable economic costs but also lead to long-term reduction of life quality.
Despite the severity of HUS, there is still no specific treatment available, and events during STEC infection of the gut which lead to systemic disease remain poorly understood. By addressing this knowledge gap, results from this work are likely to benefit HUS patients and individuals infected with STEC or at risk of STEC infection in the long term by contributing information towards treatment strategies, vaccine development, and diagnosis.

(1) Characterisation of cellular transport mechanisms involved in Stx uptake and translocation could lead to the identification of drug targets for blocking toxin access into the bloodstream and thereby provide early therapeutic intervention strategies for HUS. 

(2) Identification of STEC virulence factors involved in intestinal colonisation and/or Stx transport could identify candidate proteins for vaccine design and, as outlined in (1), lead to HUS-specific therapies.

(3) Comparison of infection and Stx production/transport characteristics of STEC strains with different virulence potential for humans could lead to the identification of select virulence markers for highly pathogenic strains which will be useful in predicting virulence potential of new isolates.

As this project is basic research, most of the outlined possibilities for impact are on a long-term scale and will need further research beyond the duration of the project. However, part 1 which will be carried out in the first year of the project, has the potential to lead to the identification of drug targets which could then be tested in vitro during the lifetime of the project (see pathways to impact).</gtr:potentialImpactText><gtr:fund><gtr:end>2015-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-07-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>408256</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Quadram Institute Bioscience</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Influence of EHEC infection on intestinal mucus production</gtr:description><gtr:id>84BAD6EB-A9C8-42D7-9EDF-DF1BE653FC0E</gtr:id><gtr:impact>Publication - Hews CL, Tran SL, Wegmann U, Brett B, Walsham AD, Kavanaugh D, Ward NJ, Juge N, Sch&amp;uuml;ller S.
Cell Microbiol. 2017 Jan 5. doi: 10.1111/cmi.12717. [Epub ahead of print]</gtr:impact><gtr:outcomeId>58ac7016dc0b62.18159651-1</gtr:outcomeId><gtr:partnerContribution>Development of mucin detection assays</gtr:partnerContribution><gtr:piContribution>N/A</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Public Health England (PHE), Claire Jenkins and Marie Chattaway</gtr:description><gtr:id>33AA4726-71D1-4DF8-99BA-E04F18F07E7A</gtr:id><gtr:impact>Oral presentation at VTEC conference, Boston, Sep 2015
Manuscript in preparation (Influence of seropathotype on Stx production, translocation and colonisation of human intestinal epithelium; Tran, Jenkins, Livrelli &amp;amp; Sch&amp;uuml;ller)
BBSRC DTP studentship (2014-2018), Adaptation of EAEC to the human gut, in collaboration with Dr Marie Chattaway</gtr:impact><gtr:outcomeId>5457c9bd3f6258.04273533-1</gtr:outcomeId><gtr:partnerContribution>PHE is determining the Stx profile of several human and bovine EHEC isolates and providing us with strains of a certain seropathotype and Stx profile for part 3 of our study.</gtr:partnerContribution><gtr:piContribution>We are participating in a current study of EHEC O157:H7 investigating the effect of multiple copies of the Shiga toxin gene (stx) on bacterial adherence, Stx production and translocation across the intestinal epithelial cells.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Verona</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Collaboration with University of Auvergne</gtr:description><gtr:id>135BD315-A7A5-4E65-BFCB-A60437F9849F</gtr:id><gtr:impact>Oral presentation at VTEC conference, Boston, Sep 2015
Manuscript in preparation (Influence of seropathotype on Stx production, translocation and colonisation of human intestinal epithelium; Tran, Jenkins, Livrelli &amp;amp; Sch&amp;uuml;ller)
Partner in Horizon 2020 ITN application, submission Jan 2016 (one PhD studentship, &amp;pound;250,000)
Partner in ERA-NET (Infect-ERA) application, Mar 2016</gtr:impact><gtr:outcomeId>566b06c20d0699.02349298-1</gtr:outcomeId><gtr:partnerContribution>Selection and provision of Stx2a-positive bovine STEC isolates</gtr:partnerContribution><gtr:piContribution>Characterisation of bovine STEC isolates regarding Shiga toxin production, translocation and colonisation in a microaerobic environment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Warwick Medical School</gtr:department><gtr:description>Meera Unnikrishnan, Wellcome Seed Award project</gtr:description><gtr:id>CE27DD1D-DF66-4139-BA93-2C269D3B2F7F</gtr:id><gtr:impact>No outputs yet.</gtr:impact><gtr:outcomeId>56d45b0bf1e1c7.14880893-1</gtr:outcomeId><gtr:partnerContribution>N/A</gtr:partnerContribution><gtr:piContribution>Collaborator on Wellcome Seed Award &amp;quot;Developing an in vitro co-culture system for investigating Clostridium difficile-host interactions&amp;quot;. Help with establishing a microaerobic vertical diffusion chamber system.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Quadram Institute Bioscience</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gut Health and Food Safety</gtr:department><gtr:description>Association of Shiga toxin with outer membrane vesicles (OMVs)</gtr:description><gtr:id>48DE7D8F-688F-4E3C-844A-77B6A7CC86AB</gtr:id><gtr:impact>Oral presentation at VTEC meeting in Boston, 2015
BBSRC DTP studentship on influence of the intestinal environment on EHEC OMV production (2016-2020)</gtr:impact><gtr:outcomeId>58ac6e9a86c2c6.75370820-1</gtr:outcomeId><gtr:partnerContribution>Training of PDRA in OMV purification and quantification methods</gtr:partnerContribution><gtr:piContribution>Development of lipid labelling techniques for OMVs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Art display at Norfolk and Norwich University Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5FC7F6E4-ACD2-4A8A-8FA2-1C06A15E6D02</gtr:id><gtr:impact>Exhibition of images of foodborne bacterial pathogens including E. coli and information about current research projects at the Norwich Research Park - prompted interest in transmission of foodborne pathogens and safe preparation of foods

Audience asked for more information on safe preparation of foods.</gtr:impact><gtr:outcomeId>5457c585a29518.17170753</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience placement (Spalding Grammar School, Lincolnshire)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7AE46AC3-B60A-4034-841E-EDEDC83284FC</gtr:id><gtr:impact>Hosting of work experience students in the lab for one week which prompted questions about research into E. coli and interest in pursuing a career in science.

Spalding Grammar School has asked for more visits next year and also circulated details to other schools in the area.</gtr:impact><gtr:outcomeId>5457c340967079.58909453</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>92000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Doctoral Training Partnership (DTP)</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>SCHULLER_F14DTP</gtr:fundingRef><gtr:id>DF1FE870-7C2D-4114-84E1-0F40FBD9D9EB</gtr:id><gtr:outcomeId>54579acaae9e72.85980897</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>92000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Doctoral Training Partnership (DTP)</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>SCH?LLER_F16FDTP2</gtr:fundingRef><gtr:id>9FFD438D-925E-4269-B5D4-382DFF6D8BFC</gtr:id><gtr:outcomeId>56d44f21ac77b3.74069089</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In this project, we have established protocols and methods for isolation of high quality EHEC mRNA from infected intestinal epithelial cells for transcriptomic analysis by RNA sequencing. This included enrichment and stabilisation of bacterial RNA by differential lysis, isolation of high-quality bacterial RNA, and depletion of ribosomal RNA.</gtr:description><gtr:id>8FCD814E-E714-4604-94E1-A8A439095279</gtr:id><gtr:impact>Enables use of RNA-seq to determine EHEC gene expression during intestinal infection. RNA-seq provides a greater dynamic range and sensitivity of transcriptomic profile compared with microarray analysis.</gtr:impact><gtr:outcomeId>5457cbcaceb054.14231588</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Isolation of EHEC mRNA from infected cells for RNA sequencing</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Establishment of protocol to isolate outer membrane vesicles (OMVs) from EHEC during human intestinal infection</gtr:description><gtr:id>04654B5A-6962-4735-8217-5F497A945A7D</gtr:id><gtr:impact>Development of this method has led to pilot data resulting in a successful DTP studentship application (Bacterial bombs or stress response - how does the environment influence production and function of bacterial outer membrane vesicles?, 2016-2020) and an MRC project application (Cross-talk between outer membrane vesicles from enterohaemorrhagic E. coli and human colonic epithelium, shortlisted for IIB meeting but not funded).</gtr:impact><gtr:outcomeId>56d45459d540b9.75695129</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Isolation of EHEC outer membrane vesicles</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>284A483F-18FC-48D4-876B-B38DC179570C</gtr:id><gtr:title>Lactobacillus reuteri Inhibition of Enteropathogenic Escherichia coli Adherence to Human Intestinal Epithelium.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f158264926848e3a8e02dccabf3590f1"><gtr:id>f158264926848e3a8e02dccabf3590f1</gtr:id><gtr:otherNames>Walsham AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>56d42d007a92d3.45368496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B93D450E-37B5-4FF3-A33C-7A61A0C331F5</gtr:id><gtr:title>Flagellin Induces ?-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular and infection microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f16935a44fa1d8781a10d1cd95b6d01"><gtr:id>3f16935a44fa1d8781a10d1cd95b6d01</gtr:id><gtr:otherNames>Lewis SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2235-2988</gtr:issn><gtr:outcomeId>585d40025ae360.40152862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A420AB4C-A51C-4A96-8E91-B88A475E6135</gtr:id><gtr:title>Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f4cba6134b3ff5900bf3c5fee278a77"><gtr:id>7f4cba6134b3ff5900bf3c5fee278a77</gtr:id><gtr:otherNames>Cepeda-Molero M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a2fd8302f4be8.97668898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E286A5B0-841E-46AC-96BB-677B6AF3FF16</gtr:id><gtr:title>Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9558d3b083b1abd878700852965790b2"><gtr:id>9558d3b083b1abd878700852965790b2</gtr:id><gtr:otherNames>Tran SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>545795e4abd6a8.88243427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CF594BB-0777-4DAB-BCA9-D0A7C1C294DC</gtr:id><gtr:title>Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f16935a44fa1d8781a10d1cd95b6d01"><gtr:id>3f16935a44fa1d8781a10d1cd95b6d01</gtr:id><gtr:otherNames>Lewis SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>doi_55f986986238d3d6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>329F6FEC-58CA-462F-A04B-2293D76B8194</gtr:id><gtr:title>The StcE metalloprotease of enterohaemorrhagic Escherichia coli reduces the inner mucus layer and promotes adherence to human colonic epithelium ex vivo.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ee9641fd55a88bb7a693a7a4d83577f"><gtr:id>4ee9641fd55a88bb7a693a7a4d83577f</gtr:id><gtr:otherNames>Hews CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>58ac69c65ed940.09275703</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J002062/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>